PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC
dc.contributor.author | Hui, R. | |
dc.contributor.author | Paz-Ares, L. | |
dc.contributor.author | Villegas, A. | |
dc.contributor.author | Daniel, D. | |
dc.contributor.author | Baz, D. V. | |
dc.contributor.author | Murakami, S. | |
dc.contributor.author | Yokoi, T. | |
dc.contributor.author | Chiappori, A. | |
dc.contributor.author | Lee, K. H. | |
dc.contributor.author | de Wit, M. | |
dc.contributor.author | Cho, B. C. | |
dc.contributor.author | Bourhaba, M. | |
dc.contributor.author | Quantin, X. | |
dc.contributor.author | Tokito, T. | |
dc.contributor.author | Mekhail, T. | |
dc.contributor.author | Planchard, D. | |
dc.contributor.author | Jiang, H. | |
dc.contributor.author | Huang, Y. | |
dc.contributor.author | Dennis, P. A. | |
dc.contributor.author | Ozguroglu, M. | |
dc.date.accessioned | 2021-03-05T12:23:40Z | |
dc.date.available | 2021-03-05T12:23:40Z | |
dc.identifier.citation | Paz-Ares L., Villegas A., Daniel D., Baz D. V. , Murakami S., Hui R., Yokoi T., Chiappori A., Lee K. H. , de Wit M., et al., "PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC", 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_acf1799d-3398-4685-9327-ed9a2d4ba54a | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/115394 | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Onkoloji | |
dc.title | PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC | |
dc.type | Bildiri | |
dc.contributor.department | CIBER - Centro de Investigacion Biomedica en Red , , | |
dc.identifier.volume | 28 | |
dc.contributor.firstauthorID | 152227 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]